| WB | 1/2000 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | 60S ribosomal protein L22, EBER-associated protein, EAP, Epstein-Barr virus small RNA-associated protein, Heparin-binding protein HBp15, RPL22 |
| Entrez GeneID | 6146 |
| WB Predicted band size | 14.8kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human, Mouse, Rat |
| Immunogen | This RPL22 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 92-121 amino acids from the C-terminal region of human RPL22. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是关于RPL22(C-term)抗体的参考文献示例(内容为示例性概括，非真实文献)：
---
1. **标题**：*RPL22 C-terminal domain mediates ribosome binding and regulates translation in leukemia*
**作者**：Zhang Y. et al.
**摘要**：研究利用RPL22(C-term)抗体，发现其C端结构域在核糖体结合中的关键作用，并揭示其在白血病细胞中通过调控特定mRNA翻译影响肿瘤发生。
2. **标题**：*Immunohistochemical analysis of RPL22 expression in colorectal cancer using C-terminal specific antibodies*
**作者**：Smith J.L. et al.
**摘要**：通过RPL22(C-term)抗体的免疫组化分析，发现结直肠癌组织中RPL22表达异常下调，提示其可能作为肿瘤抑制因子参与癌症进展。
3. **标题**：*Structural insights into RPL22 C-terminal dynamics by antibody-based probing*
**作者**：Kumar R. & Lee S.
**摘要**：利用RPL22(C-term)抗体结合X射线晶体学，解析C端构象变化对核糖体功能的影响，表明该区域在翻译延伸阶段的动态调控作用。
4. **标题**：*RPL22 interacts with EZH2 via its C-terminal domain: A study co-immunoprecipitation*
**作者**：Chen H. et al.
**摘要**：通过C端特异性抗体的免疫共沉淀实验，证实RPL22与表观调控因子EZH2的相互作用，暗示其在染色质修饰与翻译偶联中的新功能。
---
(注：以上文献为示例，实际引用需查询PubMed/Google Scholar等数据库。)
×
